Literature DB >> 22285414

Involvement of UDP-glucuronosyltranferases and sulfotransferases in the liver and intestinal first-pass metabolism of seven flavones in C57 mice and humans in vitro.

Lan Tang1, Qian Feng, Jie Zhao, Lingna Dong, Wei Liu, Caihua Yang, Zhongqiu Liu.   

Abstract

The present study investigated the involvement of UDP-glucuronosyltransferase and sulfotransferase in the extensive liver and intestinal first-pass glucuronidation and sulfation of flavones in both mice and humans. Seven structurally similar mono- and di-hydroxyflavones were chosen as model compounds. Human liver, C57 mouse liver and intestinal S9 fraction, as well as C57 intestinal perfusion model were used. In human and C57 mouse, all selected flavones were found to be glucuronidated with the highest rates at the 7-OH group. In contrast, flavones with 3-OH group were not sulfated at all. Both glucuronidation and sulfation preferred 4'- and 7-OH in human and mouse in vitro and in situ. There were differences in glucuronidation and sulfation in human and mouse observed for all flavones and it is based on substitutional positions of the hydroxyl groups. The S9 fractions could accurately model glucuronidation (as the slope of correlation curve was 0.7988 for those flavones with 4'- or 7-OH) and sulfation (as the slope of correlation curve was 0.9834) in situ. Conclusively, the sulfation and glucuronidation of the flavones was regiospecific- and speciesdependent. Sulfation and glucuronidation in the mouse intestine in vitro were correlated well with those in situ.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285414     DOI: 10.1016/j.fct.2012.01.018

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.

Authors:  Huangyu Jiang; Jia Yu; Haihui Zheng; Jiamei Chen; Jinjun Wu; Xiaoxiao Qi; Ying Wang; Xinchun Wang; Ming Hu; Lijun Zhu; Zhongqiu Liu
Journal:  Pharm Res       Date:  2017-04-18       Impact factor: 4.200

2.  Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancer.

Authors:  Xiaoyan Li; Yiyan Lu; Xiaojun Ou; Sijing Zeng; Ying Wang; Xiaoxiao Qi; Lijun Zhu; Zhongqiu Liu
Journal:  PeerJ       Date:  2020-11-18       Impact factor: 2.984

3.  Cardioprotective Effects and Possible Mechanisms of Luteolin for Myocardial Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Evidence.

Authors:  Qinyuan Pan; Yang Liu; Wenrui Ma; Rongsheng Kan; Hong Zhu; Dongye Li
Journal:  Front Cardiovasc Med       Date:  2022-04-25

4.  Establishment and use of new MDCK II cells overexpressing both UGT1A1 and MRP2 to characterize flavonoid metabolism via the glucuronidation pathway.

Authors:  Meifang Wang; Guangyi Yang; Yu He; Beibei Xu; Min Zeng; Shufan Ge; Taijun Yin; Song Gao; Ming Hu
Journal:  Mol Nutr Food Res       Date:  2016-07-06       Impact factor: 5.914

5.  Biocatalytic synthesis of acylated derivatives of troxerutin: their bioavailability and antioxidant properties in vitro.

Authors:  Xuan Xin; Mengmeng Zhang; Xiaofeng Li; Furao Lai; Guanglei Zhao
Journal:  Microb Cell Fact       Date:  2018-08-22       Impact factor: 5.328

6.  Design and Synthesis of Flavonoidal Ethers and Their Anti-Cancer Activity In Vitro.

Authors:  Lu Jin; Meng-Ling Wang; Yao Lv; Xue-Yi Zeng; Chao Chen; Hai Ren; Heng Luo; Wei-Dong Pan
Journal:  Molecules       Date:  2019-05-06       Impact factor: 4.411

7.  The independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and the metabolism of atorvastatin.

Authors:  Ju-E Liu; Bin Ren; Lan Tang; Qian-Jie Tang; Xiao-Ying Liu; Xin Li; Xue Bai; Wan-Ping Zhong; Jin-Xiu Meng; Hao-Ming Lin; Hong Wu; Ji-Yan Chen; Shi-Long Zhong
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

8.  Non-digestible stachyose promotes bioavailability of genistein through inhibiting intestinal degradation and first-pass metabolism of genistein in mice.

Authors:  Yalong Lu; Dehui Lin; Wenfeng Li; Xingbin Yang
Journal:  Food Nutr Res       Date:  2017-08-30       Impact factor: 3.894

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.